| Physical properties and biological activities of hesperetin and naringenin in complex with methylated β-cyclodextrin W Sangpheak, J Kicuntod, R Schuster, T Rungrotmongkol, P Wolschann, ... Beilstein journal of organic chemistry 11 (1), 2763-2773, 2015 | 62 | 2015 |
| Synthesis, molecular features and biological activities of modified plant polysaccharides S Mukherjee, S Jana, S Khawas, J Kicuntod, M Marschall, B Ray, S Ray Carbohydrate polymers 289, 119299, 2022 | 49 | 2022 |
| Inclusion complexation of pinostrobin with various cyclodextrin derivatives J Kicuntod, W Khuntawee, P Wolschann, P Pongsawasdi, W Chavasiri, ... Journal of Molecular Graphics and Modelling 63, 91-98, 2016 | 48 | 2016 |
| Nuclear egress complexes of HCMV and other herpesviruses: Solving the puzzle of sequence coevolution, conserved structures and subfamily-spanning binding properties M Marschall, S Häge, M Conrad, S Alkhashrom, J Kicuntod, ... Viruses 12 (6), 683, 2020 | 34 | 2020 |
| Development of a PROTAC-based targeting strategy provides a mechanistically unique mode of anti-cytomegalovirus activity F Hahn, ST Hamilton, C Wangen, M Wild, J Kicuntod, N Brückner, ... International journal of molecular sciences 22 (23), 12858, 2021 | 28 | 2021 |
| Theoretical and experimental studies on inclusion complexes of pinostrobin and β-cyclodextrins J Kicuntod, K Sangpheak, M Mueller, P Wolschann, H Viernstein, ... Scientia pharmaceutica 86 (1), 5, 2018 | 27 | 2018 |
| Combinatorial drug treatments reveal promising anticytomegaloviral profiles for clinically relevant pharmaceutical kinase inhibitors (PKIs) M Wild, J Kicuntod, L Seyler, C Wangen, LD Bertzbach, AM Conradie, ... International journal of molecular sciences 22 (2), 575, 2021 | 24 | 2021 |
| Cavity closure of 2-hydroxypropyl-β-cyclodextrin: Replica exchange molecular dynamics simulations K Kerdpol, J Kicuntod, P Wolschann, S Mori, C Rungnim, M Kunaseth, ... Polymers 11 (1), 145, 2019 | 23 | 2019 |
| A quantitative nuclear egress assay to investigate the nucleocytoplasmic capsid release of human cytomegalovirus S Häge, D Horsch, AC Stilp, J Kicuntod, R Müller, ST Hamilton, ... Journal of virological methods 283, 113909, 2020 | 19 | 2020 |
| Exploring the human cytomegalovirus core nuclear egress complex as a novel antiviral target: A new type of small molecule inhibitors S Alkhashrom, J Kicuntod, S Häge, J Schweininger, YA Muller, P Lischka, ... Viruses 13 (3), 471, 2021 | 16 | 2021 |
| Properties of oligomeric interaction of the cytomegalovirus core nuclear egress complex (NEC) and its sensitivity to an NEC inhibitory small molecule J Kicuntod, S Alkhashrom, S Häge, B Diewald, R Müller, F Hahn, ... Viruses 13 (3), 462, 2021 | 15 | 2021 |
| A peptide inhibitor of the human cytomegalovirus core nuclear egress complex S Alkhashrom, J Kicuntod, K Stillger, T Lützenburg, C Anzenhofer, ... Pharmaceuticals 15 (9), 1040, 2022 | 10 | 2022 |
| Methodological Development of a Multi-Readout Assay for the Assessment of Antiviral Drugs against SARS-CoV-2 F Hahn, S Häge, A Herrmann, C Wangen, J Kicuntod, D Jungnickl, ... Pathogens 10 (9), 1076, 2021 | 8 | 2021 |
| The Oligomeric Assemblies of Cytomegalovirus Core Nuclear Egress Proteins Are Associated with Host Kinases and Show Sensitivity to Antiviral Kinase Inhibitors J Kicuntod, S Häge, F Hahn, H Sticht, M Marschall Viruses 14 (5), 1021, 2022 | 7 | 2022 |
| An antiviral targeting strategy based on the inducible interference with cytomegalovirus nuclear egress complex J Kicuntod, S Häge, J Lösing, S Kopar, YA Muller, M Marschall Antiviral Research 212, 105557, 2023 | 4 | 2023 |
| Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers M Wild, D Karner, J Eickhoff, S Wagner, J Kicuntod, W Chang, P Barry, ... Pharmaceutics 15 (12), 2680, 2023 | 2 | 2023 |
| Properties of oligomeric interaction of the cytomegalovirus core nuclear egress complex (NEC) and its sensitivity to an NEC inhibitory small molecule. Viruses. 2021; 13: 462 J Kicuntod, S Alkhashrom, S Häge, B Diewald, R Müller, F Hahn, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| ‘Getting Better’—Is It a Feasible Strategy of Broad Pan-Antiherpesviral Drug Targeting by Using the Nuclear Egress-Directed Mechanism? J Tillmanns, J Kicuntod, J Lösing, M Marschall International Journal of Molecular Sciences 25 (5), 2823, 2024 | | 2024 |
| An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity DH Yu, S Wagner, M Schütz, Y Jeon, M Seo, J Kim, N Brückner, ... Pharmaceutics 16 (2), 158, 2024 | | 2024 |
| The cytomegalovirus nuclear egress complex: compositional and functional characterization leading to an antiviral targeting J Kicuntod Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2023 | | 2023 |
